Home > Publications database > Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation. > print |
001 | 186218 | ||
005 | 20240229145736.0 | ||
024 | 7 | _ | |a 10.1016/j.celrep.2022.111761 |2 doi |
024 | 7 | _ | |a pmid:36476851 |2 pmid |
024 | 7 | _ | |a 2211-1247 |2 ISSN |
024 | 7 | _ | |a 2639-1856 |2 ISSN |
024 | 7 | _ | |a altmetric:139743123 |2 altmetric |
037 | _ | _ | |a DKFZ-2022-03015 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Orth, Martin F |b 0 |
245 | _ | _ | |a Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation. |
260 | _ | _ | |a [New York, NY] |c 2022 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1670848912_19724 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #LA:B410# |
520 | _ | _ | |a Ewing sarcoma (EwS) is characterized by EWSR1-ETS fusion transcription factors converting polymorphic GGAA microsatellites (mSats) into potent neo-enhancers. Although the paucity of additional mutations makes EwS a genuine model to study principles of cooperation between dominant fusion oncogenes and neo-enhancers, this is impeded by the limited number of well-characterized models. Here we present the Ewing Sarcoma Cell Line Atlas (ESCLA), comprising whole-genome, DNA methylation, transcriptome, proteome, and chromatin immunoprecipitation sequencing (ChIP-seq) data of 18 cell lines with inducible EWSR1-ETS knockdown. The ESCLA shows hundreds of EWSR1-ETS-targets, the nature of EWSR1-ETS-preferred GGAA mSats, and putative indirect modes of EWSR1-ETS-mediated gene regulation, converging in the duality of a specific but plastic EwS signature. We identify heterogeneously regulated EWSR1-ETS-targets as potential prognostic EwS biomarkers. Our freely available ESCLA (http://r2platform.com/escla/) is a rich resource for EwS research and highlights the power of comprehensive datasets to unravel principles of heterogeneous gene regulation by chimeric transcription factors. |
536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a CP: Cancer |2 Other |
650 | _ | 7 | |a ChiP-seq |2 Other |
650 | _ | 7 | |a EWSR1-ERG |2 Other |
650 | _ | 7 | |a EWSR1-ETS |2 Other |
650 | _ | 7 | |a EWSR1-FLI1 |2 Other |
650 | _ | 7 | |a Ewing sarcoma |2 Other |
650 | _ | 7 | |a enhancer |2 Other |
650 | _ | 7 | |a microsatellites |2 Other |
650 | _ | 7 | |a multi-omics |2 Other |
650 | _ | 7 | |a pediatric sarcoma |2 Other |
650 | _ | 7 | |a tumor heterogeneity |2 Other |
700 | 1 | _ | |a Surdez, Didier |b 1 |
700 | 1 | _ | |a Faehling, Tobias |0 P:(DE-He78)40245f2168b87c014e445cabf610fd46 |b 2 |u dkfz |
700 | 1 | _ | |a Ehlers, Anna |0 P:(DE-He78)9b3d0cef2b1553fc9d2c5f24d91c12e1 |b 3 |u dkfz |
700 | 1 | _ | |a Marchetto, Aruna |b 4 |
700 | 1 | _ | |a Grossetête, Sandrine |b 5 |
700 | 1 | _ | |a Volckmann, Richard |b 6 |
700 | 1 | _ | |a Zwijnenburg, Danny A |b 7 |
700 | 1 | _ | |a Gerke, Julia S |b 8 |
700 | 1 | _ | |a Zaidi, Sakina |b 9 |
700 | 1 | _ | |a Alonso, Javier |b 10 |
700 | 1 | _ | |a Sastre, Ana |b 11 |
700 | 1 | _ | |a Baulande, Sylvain |b 12 |
700 | 1 | _ | |a Sill, Martin |0 P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b |b 13 |u dkfz |
700 | 1 | _ | |a Cidre-Aranaz, Florencia |0 P:(DE-HGF)0 |b 14 |
700 | 1 | _ | |a Ohmura, Shunya |0 P:(DE-He78)c25b54b0c834093d1f884d2615e305d6 |b 15 |u dkfz |
700 | 1 | _ | |a Kirchner, Thomas |0 P:(DE-He78)fd68f49dada874ac262fadf9fde869df |b 16 |u dkfz |
700 | 1 | _ | |a Hauck, Stefanie M |b 17 |
700 | 1 | _ | |a Reischl, Eva |b 18 |
700 | 1 | _ | |a Gymrek, Melissa |b 19 |
700 | 1 | _ | |a Pfister, Stefan |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 20 |u dkfz |
700 | 1 | _ | |a Strauch, Konstantin |b 21 |
700 | 1 | _ | |a Koster, Jan |b 22 |
700 | 1 | _ | |a Delattre, Olivier |b 23 |
700 | 1 | _ | |a Grünewald, Thomas |0 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c |b 24 |e Last author |u dkfz |
773 | _ | _ | |a 10.1016/j.celrep.2022.111761 |g Vol. 41, no. 10, p. 111761 - |0 PERI:(DE-600)2649101-1 |n 10 |p 111761 |t Cell reports |v 41 |y 2022 |x 2211-1247 |
909 | C | O | |o oai:inrepo02.dkfz.de:186218 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)40245f2168b87c014e445cabf610fd46 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)9b3d0cef2b1553fc9d2c5f24d91c12e1 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)45440b44791309bd4b7dbb4f73333f9b |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)c25b54b0c834093d1f884d2615e305d6 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)fd68f49dada874ac262fadf9fde869df |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 20 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)7a590ab95c6f7ba52880452da78ecd6c |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REP : 2021 |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-01-26T13:08:57Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-01-26T13:08:57Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2021-01-26T13:08:57Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-17 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-17 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-17 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL REP : 2021 |d 2022-11-17 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-17 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-17 |
920 | 2 | _ | |0 I:(DE-He78)B410-20160331 |k B410 |l Translationale Pädiatrische Sarkomforschung |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B410-20160331 |k B410 |l Translationale Pädiatrische Sarkomforschung |x 0 |
920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 1 |
920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 2 |
920 | 1 | _ | |0 I:(DE-He78)MU01-20160331 |k MU01 |l DKTK MU LMU zentral |x 3 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B410-20160331 |
980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
980 | _ | _ | |a I:(DE-He78)B062-20160331 |
980 | _ | _ | |a I:(DE-He78)MU01-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|